Bernstein Downgrades BeiGene to Market Perform, Lowers Price Target to $196
Portfolio Pulse from richadhand@benzinga.com
Bernstein analyst Rebecca Liang has downgraded BeiGene (NASDAQ:BGNE) from Outperform to Market Perform and lowered the price target from $335 to $196.
June 30, 2023 | 8:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BeiGene has been downgraded by Bernstein from Outperform to Market Perform, with a lowered price target from $335 to $196.
The downgrade from Outperform to Market Perform and the significant reduction in price target by Bernstein analyst Rebecca Liang could negatively impact investor sentiment towards BeiGene, potentially leading to a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100